Onco-Innovations Limited
Onco-Innovations Limited
Onco-Innovations Limited is a Canadian biotech company dedicated to developing and commercializing treatments for various types of cancer. The company holds an exclusive license for the PNKP Inhibitor Technology and an exclusive sublicense for the Drug Delivery Technology. Together, these technologies have shown the potential to significantly enhance treatment outcomes, particularly for colorectal cancer.
Onco-Innovations Limited (ONCO)
Onco-Innovations Limited (ONCO)
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
---|---|---|---|---|---|
Canaccord Capital Corporation | 6,000 | 1.74 | 1.76 | 1,000 | Instinet Canada Limited |
W.D. Latimer Co. Limited | 500 | 1.68 | 1.79 | 400 | Anonymous |
W.D. Latimer Co. Limited | 500 | 1.65 | 1.80 | 500 | Anonymous |
W.D. Latimer Co. Limited | 500 | 1.60 | 1.85 | 500 | Anonymous |
W.D. Latimer Co. Limited | 1,000 | 1.55 | 1.90 | 500 | Anonymous |
Questrade Inc. | 1,000 | 1.53 | 1.94 | 2,500 | Virtu Canada Corp. |
Anonymous | 500 | 1.52 | 2.00 | 500 | Anonymous |
W.D. Latimer Co. Limited | 1,000 | 1.50 | 2.05 | 100 | National Bank Financial Inc. |
Canaccord Capital Corporation | 5,000 | 1.50 | 2.10 | 2,000 | National Bank Financial Inc. |
Canaccord Capital Corporation | 5,000 | 1.45 | 2.20 | 1,000 | TD Securities Inc. |
Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
---|---|---|---|---|---|
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 |
Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
---|---|---|---|---|---|
1 | 6,000 | 1.74 | 1.76 | 1,000 | 1 |
1 | 500 | 1.68 | 1.79 | 400 | 1 |
1 | 500 | 1.65 | 1.80 | 500 | 1 |
1 | 500 | 1.60 | 1.85 | 500 | 1 |
1 | 1,000 | 1.55 | 1.90 | 500 | 1 |
Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
---|---|---|---|---|---|
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
---|---|---|---|---|---|---|
Mar 28, 19:59 | 1.76 | 0.06 | 1,000 | Anonymous | Instinet Canada Limited | CSE |
Mar 28, 19:59 | 1.76 | 0.06 | 500 | Canaccord Capital Corporation | Instinet Canada Limited | CSE |
Mar 28, 19:59 | 1.76 | 0.06 | 1,000 | Canaccord Capital Corporation | Instinet Canada Limited | CSE |
Mar 28, 19:59 | 1.76 | 0.06 | 1,000 | Canaccord Capital Corporation | Instinet Canada Limited | CSE |
Mar 28, 19:59 | 1.76 | 0.06 | 1,000 | Canaccord Capital Corporation | Instinet Canada Limited | CSE |
Company Info
SEDAR Information
Company Info
Capitalization
Company Officers
Bulletins
2024-1133 - New Listing - Onco-Innovations Limited (ONCO)
Le 26 novembre/November 2024
The common shares of Onco-Innovations Limited have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.